| 000 | 01491 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517192306.0 | ||
| 264 | 0 | _c20180815 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a1573-4935 | ||
| 024 | 7 |
_a10.1042/BSR20170730 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, Zhi-Jian | |
| 245 | 0 | 0 |
_aEvaluation of efficacy and safety of Reteplase and Alteplase in the treatment of hyper-acute cerebral infarction. _h[electronic resource] |
| 260 |
_bBioscience reports _c02 2018 |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAspirin _xadministration & dosage |
| 650 | 0 | 4 |
_aCerebral Infarction _xblood |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aQiu, Hong-Yan | |
| 700 | 1 | _aTong, Xiao-Xin | |
| 700 | 1 | _aGuo, Yi | |
| 700 | 1 | _aHan, Man-Fu | |
| 700 | 1 | _aYang, Chun-Shui | |
| 700 | 1 | _aLin, Kai-Hua | |
| 700 | 1 | _aWu, Jun | |
| 700 | 1 | _aLi, Xing | |
| 700 | 1 | _aYang, Yang | |
| 773 | 0 |
_tBioscience reports _gvol. 38 _gno. 1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1042/BSR20170730 _zAvailable from publisher's website |
| 999 |
_c27910741 _d27910741 |
||